The Biogen Bump Bodes Well for Biotech

The Biogen Bump Bodes Well for Biotech

Submitted by admin on July 7, 2018 - 4:32pm
Source: 
Barron's
News Tags: 
Biogen
Eisai
Alzheimer's disease
BAN2401
Headline: 
The Biogen Bump Bodes Well for Biotech
snippet: 
Shares of Biogen (BIIB) took off following upbeat trial data for an Alzheimer’s treatment—and it could be a sign that it’s safe to start nibbling on the shares of other big biotech stocks as well.

Do Not Allow Advertisers to Use My Personal information